Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FJA06
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,226
Award facts
- Contract value 100% obligated
- $15,225.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,225.68 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens. This competitively awarded, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which enables the company to distribute a broad range of brand-name and generic medications, vaccines, and medical supplies to military and veteran healthcare systems. Cosentyx is a specialty biologic medication used to treat various autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. No set-aside designation was applied to this award, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement processes for specialized pharmaceutical commodities supporting the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB25FJA06?
SPE2DB25FJA06 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FJA06 worth?
The government has obligated $15,226 on SPE2DB25FJA06.
Is contract SPE2DB25FJA06 an order under another contract?
Yes. SPE2DB25FJA06 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJA06 competed?
The extent of competition for SPE2DB25FJA06 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award